Min-Yuan Chou

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Industrial Technology Research Institute. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min-Yuan Chou. Retrieved from https://idiyas.com/inventor/min-yuan-chou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 86.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Taipei Hsien, TW (2005 - 2010)
Taipei County, TW (2019)
Taipei, TW (2014 - 2023)

Company Filing History:

15 out of 9,303

Industrial Technology Research Institute

patents

Years Active: 2005-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735483 - ANTI-TIGIT ANTIBODIES AND METHODS OF USE (2026-09-15),

2. 12275953 - Methods for screening host cells expressing target proteins (2025-04-14),

3. 11788129 - Nucleic acid detection kit and nucleic acid detection method (2023-10-17),

4. 11667709 - Anti-TIGIT antibodies and methods of use (2023-06-06),

5. 10604586 - Humanized monoclonal antibody and uses thereof (2020-03-31),

6. 10329350 - Method for producing a multivalent fab fragment with collagen-like peptide (2019-06-25),

7. 10183986 - Trimeric collagen scaffold antibodies (2019-01-22),

8. 8927696 - Humanized anti-human CD34 monoclonal antibody and uses thereof (2015-01-06),

9. 8758756 - Anti-human epidermal growth factor receptor antibody and uses thereof (2014-06-24),

10. 8691226 - Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof (2014-04-08),

11. 8669350 - TNF receptor Fc fusion proteins and in vivo methods of use (2014-03-11),

12. 8663598 - Anti-human transferrin receptor antibody and uses thereof (2014-03-04),

13. 7759090 - Expression system for producing collagen (2010-07-20),

14. 7279329 - Expression system for producing collagen (2007-10-09),

15. 6903200 - Human α1 chain collagen (2005-06-07),

Title: Inventor Min-Yuan Chou: Pioneering Advances in Nucleic Acid Detection and Immunotherapy

Introduction

Min-Yuan Chou is a distinguished inventor based in Taipei, Taiwan, who has made significant contributions to the fields of biotechnology and immunotherapy. With a total of 13 patents to his name, Chou's work plays a crucial role in advancing medical diagnostics and treatments for complex diseases.

Latest Patents

Among his most recent innovations is the development of a nucleic acid detection kit and a corresponding detection method. This kit focuses on the detection of GAPDH nucleic acids and includes a comprehensive primer set featuring forward and backward inner and outer primers. The unique aspect of this kit is its implementation of loop-mediated isothermal amplification (LAMP), a technique that enhances the efficiency and reliability of nucleic acid detection.

Another notable patent covers anti-TIGIT antibodies and their therapeutic applications. These antibodies and antigen-binding fragments target TIGIT, a crucial player in immune regulation. The patent encompasses methods and compositions designed to treat immune-related diseases, such as certain cancers and infections, by employing these innovative antibodies.

Career Highlights

Min-Yuan Chou is currently associated with the Industrial Technology Research Institute, where he applies his expertise to drive research and development in cutting-edge technologies. His contributions have not only advanced academic knowledge but have also had a practical impact on medical diagnostics and therapeutic strategies.

Collaborations

Throughout his career, Chou has collaborated with notable colleagues, including Hsiu-Chuan Li and Chuan-Chuan Huang. These partnerships highlight the collaborative spirit that underpins innovation in research and development, allowing for the exchange of ideas and advancements in patented technologies.

Conclusion

As an inventor, Min-Yuan Chou continues to push the boundaries of science and technology. His latest patents reflect a commitment to improving healthcare through innovative solutions in nucleic acid detection and immunotherapy. With a robust portfolio of patents and an impactful career at the Industrial Technology Research Institute, Chou's contributions will likely influence the future of medical research and treatment methodologies.

Profile summary based on public USPTO records.